Detalhe da pesquisa
1.
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys.
Cell
; 155(3): 531-9, 2013 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24243013
2.
Full-length HIV-1 immunogens induce greater magnitude and comparable breadth of T lymphocyte responses to conserved HIV-1 regions compared with conserved-region-only HIV-1 immunogens in rhesus monkeys.
J Virol
; 86(21): 11434-40, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22896617
3.
Definition of the viral targets of protective HIV-1-specific T cell responses.
J Transl Med
; 9: 208, 2011 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-22152067
4.
T cell responses in HIV type 1-infected adolescent minorities share similar epitope specificities with whites despite significant differences in HLA class I alleles.
AIDS Res Hum Retroviruses
; 19(11): 1017-26, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14678609
5.
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.
Nat Med
; 16(3): 319-23, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20173752
6.
Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities.
J Acquir Immune Defic Syndr
; 33(4): 426-38, 2003 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12869831